Zaragoza, septiembre de 2012.- Con la ponencia titulada “Endoablación mediante el uso de vapor”, el Dr. Gerardo Pastor Mena, cirujano vascular de la Clínica Quirón de Zaragoza, ha presentado en el XVI Congreso Internacional FVL de Chile su experiencia con la técnica de vapor de agua (SVS).
On 11 September 2012, Healthpoint Biotherapeutics announced the initiation of a phase III clinical trial investigating the efficacy of HP802-247 for the treatment of venous leg ulcers. HP802-247 is an investigational allogeneic living cell bioformulation containing keratinocytes and fibroblasts. The study is designed to evaluate complete wound closure in subjects receiving HP802-247 plus compression therapy compared to those receiving vehicle control plus compression therapy over the 12-week treatment period.
Bio DG announced on 10 September 2012 that its patent for a novel metal system for use as biodegradable material in developing implantable medical devices was granted by the US Patent Office on 21 August 2012.
Biotronik has introduced its Pulsar stent technology in a 0.035”/6F platform and Passeo-14 balloon catheter, a dedicated 0.014” infrapopliteal percutaneous transluminal angioplasty (PTA) catheter, for lower limb treatment.
Following the success of BIOTRONIK s Pulsar-18 0.018"/4F-platform self-expanding stent system, the company has now introduced its Pulsar stent technology in a 0.035"/6F platform. With this, BIOTRONIK is offering even more physicians its high qualitative stent technology with its high technical success and encouraging clinical performance.
Endologix has announced CE mark approval of the current version of the Nellix EndoVascular Aneurysm Sealing System for the treatment of patients with abdominal aortic aneurysms.
The Vascular Society of Great Britain & Ireland (VSGBI) and the Royal College of Physicians have released the UK Carotid Endarterectomy Audit Round 4. This fourth public report from the Carotid Interventions Audit demonstrates continuing improvement in the service that hospital teams provide to patients.
David Deaton, chief, Vascular and Endovascular Surgery, MedStar Georgetown University Hospital, Washington, DC, USA, presented on the endostapling technology and aortic neck dilatation after EVAR at the Vascular Annual Meeting in National Harbor, USA.
The new Crux inferior vena cava filter can be implanted and retrieved safely and shows a low rate of pulmonary embolism, Anthony J Comerota, director, Jobst Vascular Institute, adjunct professor of Surgery, University of Michigan, USA, told delegates at the Vascular Annual Meeting (7–9 June 2012). He spoke about new developments with inferior vena cava filters at the conference in National Harbor, USA.
For many diabetics, monitoring their condition involves much more than adhering to a routine of glucose sensing and insulin injections. It also entails carefully monitoring the ongoing toll this disease takes on their body.
A new study published in the September print issue of the Journal of Vascular Surgery reveals that rural and urban patients have equivalent access to endovascular aneurysm repair (EVAR) care from vascular surgeons, increased referral to high-volume hospitals and improved outcomes after repair.
Twelve-month results from the CALCIUM 360° study have shown that orbital atherectomy with balloon angioplasty (BA) provide significantly lower major serious adverse events (major amputation, all-cause mortality, and TLR/TVR) than balloon angioplasty alone when used in the treatment of calcified infrapopliteal arteries in patients with critical limb ischaemia.
A new study raises a cautionary note about the increasing use of a minimally invasive procedure to repair ruptured abdominal aortic aneurysms, according to vascular surgeon Dr. Jae Sung Cho of Loyola University Medical Center.
Depression was linked with an increased risk of peripheral arterial disease (PAD) in a study of more than 1,000 men and women with heart disease conducted by researchers at the San Francisco VA Medical Center and the University of California, San Francisco, USA. Results of a sub-analysis from The Heart and Soul study were recently published on the Journal of the American Heart Association (online version).
Sapheon announced one year data in a 38-patient clinical study of the VenaSeal Sapheon Closure System, an advanced approach to the treatment of saphenous vein disease based on a proprietary medical adhesive.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos